Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...

Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes ...

Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...

With shortages of Ozempic at U.S. pharmacies, some Americans have been turning to Canada and Mexico to buy the medication, a Type 2 diabetes treatment many people are using off-label to lose weight.

Ozempic (semaglutide) is a GLP-1 RA (glucagon-like peptide-1 receptor agonist), also known as a “GLP-1” drug. It’s an effective medication for managing type 2 diabetes and for weight loss.

Ozempic causes fast weight loss all over your body. You may not realize it, but fat holds your skin up and even keeps it tight or firm in some places, such as on your face and your rear end.

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...